Regulation of microglia by glutamate and its signal pathway in neurodegenerative diseases

Xinyue Zhang1, Dan Wang2, Bo Zhang3

  • 1Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China; Department of Neurobiology, Care Sciences & Society, Division of Neurogeriatrics, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.

Drug Discovery Today
|April 23, 2020
PubMed

Insights

Microglia, the central nervous system’s immune cells, play key roles in neuroinflammation and neurodegenerative diseases. Understanding microglial characteristics and glutamate signaling offers a promising therapeutic strategy for these conditions.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are vital immune cells in the central nervous system (CNS).
  • They participate in host defense, neuroinflammation, homeostasis, and tissue repair.
  • Microglial dysfunction contributes to neurodegenerative disease pathogenesis.

Purpose of the Study:

  • To review recent advancements in characterizing microglia.
  • To explore the role of glutamate and its receptors in microglial regulation.
  • To identify potential therapeutic targets for neurodegenerative diseases.

Main Methods:

  • Literature review of recent studies on microglia and glutamate.
  • Analysis of microglial diversity and multifunctionality.
  • Examination of glutamate receptor signaling in microglia.

Main Results:

  • Microglial characteristics are diverse and context-dependent.
  • Glutamate signaling significantly influences microglial functions.
  • Specific glutamate receptors are implicated in microglial responses.

Conclusions:

  • Microglial diversity is critical for their roles in CNS health and disease.
  • Targeting glutamate pathways in microglia presents a novel therapeutic avenue.
  • Further research into microglial-glutamate interactions is warranted for treating neurodegenerative disorders.